The Canadian unit of American tech giant IBM (NYSE:IBM) has partnered with pharmaceutical company Boehringer Ingelheim to deploy blockchain in clinical recordkeeping, according to a press release published on Feb. 12.
The cooperation between the two companies aims to test whether the integration of blockchain technology with clinical recordkeeping provides the proper level of data integrity, transparency, and patient safety, in addition to reducing costs and automating processes.